ORN
Orion Group Holdings, Inc.
ORN has lower modeled downside risk, despite its lower overall score.
RKLB
Rocket Lab USA, Inc.
RKLB has the edge over ORN overall, supported by stronger fundamentals and stronger valuation.
ORN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Under pressure |
ORN's revenue is currently healthy, and its profitability is stable, but its cash flow and balance sheet are under pressure.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
ORN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.7x | $1.40 | -82% |
| Fair | 21x | $3.30 | -57% |
| Forward | 27x | $7.65 | — |
| Current | 48x | $7.65 | — |
| Expensive | 85x | $13.65 | +78% |
Historical ranges are pointers, not guarantees.
ORN's PE is in its expensive range at 48x. If earnings grow as analysts expect, today's price would be 27x next year's earnings, in its fair range.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
ORN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for ORN, with profitability holding steady. However, they disagree widely on these estimates.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over ORN on the outlook, with more favorable profitability expectations.
ORN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.28 | +76% |
| Q3 2026 | $0.16 | -43% |
| Q2 2026 | $0.10 | -69% |
| Q1 2026 | $0.22 | +120% |
| Q4 2025 | $0.06 | +$0.11 |
| Q3 2025 | $0.28 | +$0.68 |
| Q2 2025 | $0.32 | +$0.86 |
| Q1 2025 | $0.10 | +$0.45 |
| Q4 2024 | -$0.05 | +$0.50 |
ORN has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
ORN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $256.2M | +14% |
| Q2 2026 | $221.9M | +8.1% |
| Q1 2026 | $216.3M | +15% |
| Q4 2025 | $233.2M | +7.5% |
| Q3 2025 | $225.1M | -0.7% |
| Q2 2025 | $205.3M | +6.8% |
| Q1 2025 | $188.7M | +17% |
| Q4 2024 | $216.9M | +7.6% |
ORN's revenue has grown year over year for four quarters in a row: $256M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.3% | +1 points |
| Q2 2026 | -0.6% | -2.3 points |
| Q1 2026 | -0.4% | -0.8 points |
| Q4 2025 | 2.1% | -2.3 points |
| Q3 2025 | 2.4% | -1.1 points |
| Q2 2025 | 1.7% | +3.1 points |
| Q1 2025 | 0.4% | +2.4 points |
| Q4 2024 | 4.4% | +4.7 points |
ORN has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over ORN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
ORN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6M | -143% |
| Q2 2026 | -$29.2M | -$16.5M |
| Q1 2026 | -$3.7M | +$8.8M |
| Q4 2025 | $454K | -95% |
| Q3 2025 | $13.9M | -58% |
| Q2 2025 | -$12.7M | +$7.3M |
| Q1 2025 | -$12.5M | +$12.2M |
| Q4 2024 | $9.9M | -77% |
ORN has burned cash in most quarters: −$38M over the past year, against −$1M the year before.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
ORN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +39.6K shares |
| 1 year | +1.8% | +731K shares |
| 3 years | +25% | +8.1M shares |
| 5 years | +31% | +9.5M shares |
| Available history | +38% | +11.2M shares |
ORN has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | $164,000 |
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
ORN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.4x | Elevated |
| Q2 2026 | 3.8x | Elevated |
| Q1 2026 | 2.4x | Moderate |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.9x | Very low |
| Q1 2025 | 0.4x | Very low |
| Q4 2024 | -0.2x | Net Cash |
ORN's net debt is about 3.4 years of its operating earnings (EBITDA), up from less than a year a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ORN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.0 | Neutral |
| Stochastic | 13.2 | Oversold |
ORN's weekly RSI is 34 (neutral) and its Stochastic is 13 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
ORN PE vs Industrials Sector
| Metric | ORN | Sector median | Relative |
|---|---|---|---|
| PE | 48x | 24x | 99% above |
| PE % | 67 | 58 | 9 pts above |
ORN is trading at 48x earnings, a 99% premium to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
ORN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.44 | 9.4% below |
| 20 week MA | $9.89 | 23% below |
| 50 week MA | $11.5 | 33% below |
| 100 week MA | $9.65 | 21% below |
| 200 week MA | $7.62 | 0.4% above |
ORN has fallen below most of its moving averages, though it's still 0.4% above its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over ORN on trend strength, trading above more of its moving averages.
ORN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.00 | $4.94 | -1.2% |
| 2021 | $4.94 | $3.78 | -23% |
| 2022 | $3.78 | $2.29 | -39% |
| 2023 | $2.29 | $4.94 | +116% |
| 2024 | $4.94 | $7.53 | +52% |
| 2025 | $7.53 | $10.4 | +38% |
| 2026 YTD | $10.4 | $7.65 | -27% |
ORN has finished lower in three of the last six years. It's down 27% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over ORN on returns for 2026, with the stronger performance.